##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||funds|funds|funds|funds|
|||Note|2020
6|2020f|2020f|2019f|
|Income from:|||||||
|Donations
and legacies|||96,840||96,840|76,920|
|Charitable
activities|||573,699|75,913|649,611|898,189|
|Other trading
activities|||15,228||15,228|22,761|
|Investments|||299||299|643|
|Total income|||686,066|75,913|761,979|998,513|
|Expenditure
on:|||||||
|Raising funds|||23,852||23,852|32,467|
|Charitable
activities|||467,239|121,197|588,436|886,775|
|Total expenditure|||491,091|121,197|612,288|919,242|
|Net gains/(losses)|on investments||(104,301)||(104,301)|151,186|
|Net income/(expenditure)|||90,674|(45,284)|45,390|230,457|
|Transfers
between|funds|20|(200,000)|200,000|||
|Net movement
in|funds||(109,326)|154,716|45,380|230,457|
|Reconciliation
of|funds:||||||
|Total funds brought|forward||1 190)301|187~462|1,377,763|1,147,306|
|Net movement
in funds|||(109,326)|154,716|45,390|230,457|
|Total funds carried forward|||1,080,975|342,178|1,423,153|1,377,763|
##
##
##
|||||2020||2019|
|---|---|---|---|---|---|---|
|||Note||5||5|
|Fixed assets|||||||
|Intangible
assets||13||3,600||4,200|
|Tangible assets||14||4,289||5,363|
|Investments||15||704,580||808,881|
|||||712,469||818,444|
|Current assets|||||||
|Debtors||16|470,200||427,304||
|Cash at bank and|in hand||570,835||529,271||
||||1,041,035||956,575||
|Creditors: amounts|falling due within one||||||
|year||17|(329,341)||(395,573)||
|Net current assets||||711,694||561,002|
|Total assets less|current liabilities|||1,424,163||1,379,445|
|Creditors: amounts|falling due after more||||||
|than one year||18||(1,010)||(1,683)|
|Total net assets||||1,423,153||1,377,763|
|Charity funds|||||||
|Restricted funds||20||342,178||187,462|
|Unrestricted
funds||20||1,080,975||1,190,301|
|Total funds||||1,423,153||1,377,783|
##
##
##
##
|||||||2020|2019|
|---|---|---|---|---|---|---|---|
|||||||5|8|
|Cash flows from operating|||activities|||||
|Net cash|used
in operating|activities (see||Note 24)||43,070|115,400|
|Cash flows from investing|||activities|||||
|Dividends,|interests
and rents from investments|||||299|643|
|Purchase|oftangible
fixed assets|||||(1,805)||
|Net cash|(used in)/provided||by investing||activities|(1,506)|643|
|Cash flows from financing|||activities|||||
|Net cash|provided
by financing
activities|||||||
|Change
in cash and cash|||equivalents|in|the year|41,564|116,043|
|Cash and|cash equivalents||at the beginning||ofthe year|529,271|413,228|
|Cash and|cash equivalents||atthe end|of|the year (see Note 24)|570,835|529,271|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|Short leasehold|property|Over the period|ofthe lease|
|---|---|---|---|
|Office furniture,|fittings and|20% on the straight|line basis|
|equipment||||
|Computer
equipment||33% on the straight|line basis|
|Intangible
fixed|asset|5% on the straight|line basis|
##
##
##
##
##
##
##
##
##
##
##
##
##
|3.|Income from|donations|donations|and|legacies||||
|---|---|---|---|---|---|---|---|---|
|||||||Unrestricted|Total|Total|
|||||||funds|funds|funds|
|||||||2020|2020|2019|
|||||||E|E|E|
||Sponsorship|donations||||96,840|96,840|76,920|
||Total 2019|||||76,920|76,920||
|4.|Income from|charitable||activities|||||
|||||||Unrestricted|Restricted|Total|
|||||||funds|funds|funds|
|||||||2020|2020|2020|
|||||||E|E|E.|
||Meetings
income|||||217,328||217,328|
||Annual
subscriptions|||||255,668||255,668|
||Special Certificate Examination||||income|40,806||40,806|
||Clinical Research Training|||Fellowship|||75,913|75,913|
||Practical Neurology||income|||59,897||59,897|
||Roger Bannister Fellowship||||||||
||Total 2020|||||573,699|75,913|649,612|
##
##
##
##
|||||||||Unrestricted|Restricted|Total|
|---|---|---|---|---|---|---|---|---|---|---|
|||||||||funds|funds|funds|
|||||||||2019
F|2019f|2019f|
||Meetings|income||||||450,873||450,873|
||Annual
subscriptions|||||||233,825||233,825|
||Special Certificate Examination|||||income||38,206||38,206|
||Clinical Research||Training||Fellowship||||117,724|117,724|
||Practical|Neurology||income||||56,630||56,630|
||Roger Bannister||Fellowship||||||931|931|
||Total 2019|||||||779,534|118,655|898,189|
|5.|Income|from other||trading|activities||||||
||Income|from fundraising|||events||||||
|||||||||Unrestricted|Total|Total|
|||||||||funds|funds|funds|
|||||||||2020|2020|2019|
|||||||||E|E|E|
||Hire and|sublet ofoffice space||||||15,228|15,228|16,848|
||RaDar income|||||||||1,050|
||Total 2020|||||||15,228|15,228|17,898|
||Total 2019|||||||17,898|17,898||
||Income|from non charitable||||trading|activities||||
||||||||||Total|Total|
||||||||||funds|funds|
||||||||||2020f|2019f|
||Sales of|merchandise||||||||4,863|
##
##
||||||Unrestricted|Total|Total|
|---|---|---|---|---|---|---|---|
||||||funds|funds|funds|
||||||2020|2020|2019|
||||||E|F.|E|
|Allocated|centrally|incurred||support costs|23,852|23,852|25,396|
|Other trading expenses||||||||
|||||||Total|Total|
|||||||funds|funds|
|||||||2020|2019|
|||||||F|F|
|Cost ofmerchandise|||sold||||7,071|
##
||||Grant|||
|---|---|---|---|---|---|
||||funding|Support|Total|
|||Direct costs|(Note 9)|costs|funds|
|||2020|2020|2020|2020|
|||E|E|E||
|Chadtable|activities|193,207|121,197|274,031|588,435|
##
##
##
##
||||Grant|||
|---|---|---|---|---|---|
||||funding|Support|Total|
|||Direct costs|(Note 9)|costs|funds|
|||2019|2019|2019|2019|
|||6|6|8|8|
|Charitable|activities|486,068|108,648|292,060|886,776|
|Analysis|ofdirect costs|||||
|||||||Total|Total|
|---|---|---|---|---|---|---|---|
|||||||funds|funds|
|||||||2020|2019|
|||||||F||
|Meetings|expenditure|||||66,638|344,287|
|Meetings|consultancy|||||44,040|48,000|
|General|and committee|||meeting|expenses|3,691|13,686|
|Charles|Symonds|Prize||||600|600|
|Educationalsupport||||||3,263|700|
|ABN representation|||at other meetings||||4,218|
|Professional
subscriptions||||||8,075|7,311|
|Practical|Neurology||subscription|||40,000|40,000|
|Specialty|Certificate||Examination||expenditure|27,000|27,266|
|||||||193,207|488,068|
##
##
##
##
|Analysis ofsupport cost|s (continued)|||
|---|---|---|---|
|||Total|Total|
|||funds|funds|
|||2020
f|2019
F|
|Staff costs||183,649|188,838|
|Office rent, rates and service charges||58„857|51,210|
|Website||15,502|30,050|
|Office running
expenses||12,904|17,716|
|Fellowship
support costs||1,216|4,666|
|Computer costs||3,218|1,824|
|Stafftraining||199||
|Consultancy
fees|||1,800|
|Audit and accountancy||6,300|7,080|
|Loss on disposal oftangible fixed asset|||3|
|Legal and professional||7,085|6,307|
|Bank charges||3,429|2,908|
|Finance lease charges||209|157|
|Loss on foreign exchange||447||
|Depreciation||3,478|3,063|
|Sundry expenses||1,392|1,834|
|Reallocated to fundraising|costs|(23,852)|(25,396)|
|||274,031|292,060|
##
|||||Grants to|Total|
|---|---|---|---|---|---|
|||||Individuals|funds|
|||||2020
f.|2020f|
|Clinical|Research|Training|Fellowship|121,197|121,197|
##
##
##
##
|||||Grants to|Total|
|---|---|---|---|---|---|
|||||Individuals|funds|
|||||2019|2019|
|||||6|6|
|Clinical|Research|Training|Fellowship|108,648|108,648|
##
##
|Staffcosts||||||
|---|---|---|---|---|---|
|||||2020|2019f|
|Wages and|salaries|||157,221|160,259|
|Social security costs||||10,706|12,194|
|Contribution|to defined|contribution|pension schemes|15,722|16,385|
|||||183,649|188,838|
|2020|2019|
|---|---|
|No.|No.|
##
##
##
##
##
##
|Intangible assets||
|---|---|
||Coat ofarms|
||F|
|Cost||
|At 1 January 2020|12,000|
|At 31 December 2020|12,000|
|Amortisation||
|At 1 January 2020|7,800|
|Charge for the year|600|
|At 31 December 2020|8,400|
|Net book value||
|At 31 December 2020|3,600|
|At 31 December 2019|4,200|
##
##
##
##
||Short-term||||
|---|---|---|---|---|
||leasehold|Fixtures and|Computer||
||property|fittings|equipment|Total|
||E|5|E|F|
|Cost or valuation|||||
|At 1 January 2020|19,891|26,822|4,195|50,908|
|Additions||517|1,287|1,804|
|At 31 December 2020|19,891|27,339|5,482|52,712|
|Depreciation|||||
|At 1 January 2020|19,890|21,804|3,851|45,545|
|Charge for the year||1,887|990|2,877|
|At 31 December 2020|19,890|23,691|4,841|48,422|
|Net book value|||||
|At 31 December 2020|1|3,648|641|4,290|
|At 31 December 2019|1|5018|344|5,363|
##
##
##
||Listed|
|---|---|
||investments|
||6|
|Cost or valuation||
|At 1 January 2020|808,881|
|Revaluations|(104,301)|
|At 31 December 2020|704,580|
|Net book value||
|At 31 December 2020|704,580|
|At 31 December 2019|806,881|
##
##
|||2020|2019|
|---|---|---|---|
||||E|
|Due within one year||||
|Arrears ofsubscriptions||3,549|1,568|
|Other debtors||79,417|102,367|
|Prepayments|and accrued income|287,457|323,369|
|Sponsorship|income receivable|99,777||
|||470,200|427,304|
##
##
##
##
|17.|Creditor|s: Amounts|falling|due within one y|ear|||
|---|---|---|---|---|---|---|---|
|||||||2020|2019|
|||||||5||
||Other taxation and social security|||||79|127|
||Net obligations
under||finance|leases||673|673|
||Pension|fund loan payable||||1,090|3,317|
||Other creditors|||||33,757|47,446|
||Accruals|and deferred|income|||293,742|344,010|
|||||||329,341|395,573|
||The above
includes||deferred|income of F126,156 (2019 - 5123,898) relating||to annual|subscriptions|
||received|in advance which may be analysed as|||follows:-|||
|||||||2020|2019|
||Deferred|income at 1|January|2020||123,898|113,158|
||Amount|deferred
during the year||||126,156|123,898|
||Amounts|released to|incoming|resources||(123,898)|(113,158)|
|||||||126,156|123,898|
|18.|Creditors: Amounts||falling due after more than one year|||||
|||||||2020
f.|2019f|
||Net obligations
under||finance|leases||1,010|1,683|
|19.|Financial instruments|||||||
|||||||2020|2019|
||||||||5|
||Financial assets|||||||
||Financial|assets measured
at||fair value through|income and expenditure|570,835|529,271|
##
##
##
||||||||Balance at|
|---|---|---|---|---|---|---|---|
|||Balance at 1|||||31|
|||January|||Transfers|Gains/|December|
|||2020|Income|Expenditure|in/out|(Losses)|2020|
|||6|E|K|E|F|E|
|Unrestricted||||||||
|funds||||||||
|General|Funds|531,420|686,066|(491,091)|(200,000)||526,395|
|Revaluation||||||||
|reserve||658,881||||(104,301)|554,580|
|||1,190,301|686,066|(49'l,091)|(200,000)|(104,301)|1,080,975|
|Restricted||||||||
|funds||||||||
|Clinical||||||||
|Research||||||||
|Training||||||||
|Fellowship||171,719|75,913|(121,197)|200,000||326,435|
|Roger Bannister||||||||
|Fellowship||15,743|||||15,743|
|||187,462|75,913|(121,197)|200,000||342,178|
|Total offunds||1,377,763|761,979|(612,288)||(104,301)|1,423,153|
##
##
##
##
##
|Statement|offunds (continued)||||||
|---|---|---|---|---|---|---|
|Statement|offunds - prior year||||||
|||||||Balance at|
|||Balance at||||31|
|||1 January|||Gains/|December|
|||2019
F|Income|Expenditure
F|(Losses)f|2019
F|
|Unrestricted|funds||||||
|General
Funds||462,157|879,858|(810,595)||531,420|
|Revaluation|reserve|507,695|||151,186|658,881|
|||969,852|879,858|(810,595)|151,186|1,190,301|
|Restricted funds|||||||
|Clinical Research Training|||||||
|Fellowship||162,643|117,724|(108,648)||171,719|
|Roger Bannister Fellowship||14,812|931|||15,743|
|||177,455|118,655|(108,648)||187,462|
|Total offunds||1,147,307|998,513|(919,243)|151,186|1,377,763|
##
|Summary
offun|ds - current year||||||
|---|---|---|---|---|---|---|
|||||||Balance at|
||Balance at 1|||||31|
||January|||Transfers|Gains/|December|
||2020|Income|Expenditure|in/out|(Losses)|2020|
||6|6||E||6|
|General funds|1,190,301|686,066|(491,091)|(200,000)|(104,301)|1,080,975|
|Restricted funds|187,462|75,913|(121,197)|200,000||342,178|
||1,377,763|761,979|(612,288)||(104,301)|1,423,153|
##
##
##
##
||||||Balance at|
|---|---|---|---|---|---|
||Balance at||||31|
||1 January|||Gsinai|December|
||2019
f.|Income
f.|Expenditure
f|(Losses)f|2019f|
|General funds|969,852|879,858|(810,595)|151,186|1,190,301|
|Restricted funds|177,455|118,655|(108,648)||187,462|
||1,147,307|998,513|(919,243)|151,186|1,377,763|
|||Unrestricted|Restricted|Total|
|---|---|---|---|---|
|||funds|funds|funds|
|||2020f|2020f|2020f|
|Tangible|fixed assets|4,289||4,289|
|Intangible|fixed assets|3,600||3,600|
|Fixed asset investments||704,580||704,580|
|Current assets||547,498|493,537|1,041,035|
|Creditors|due within one year|(177,982)|(151,359)|(329,341)|
|Creditors|due in more than one year|(1,010)||(1,010)|
|Total||1,080,975|342,178|1,423,153|
##
##
##
##
|||Unrestricted|Restricted|Total|
|---|---|---|---|---|
|||funds|funds|funds|
|||2019f|2019f|2019f|
|Tangible|fixed assets|5,363||5,363|
|Intangible|fixed assets|4,200||4,200|
|Fixed asset investments||808,881||808,881|
|Current assets||577,781|378,794|956,575|
|Creditors|due within one year|(204,241)|(191,332)|(395,573)|
|Creditors|due in more than one year|(1,683)||(1,683)|
|Total||1,190,301|187,462|1,377,763|
##
|Reconciliation
of|net movement||in funds|to net cash flow from operating|activities||
|---|---|---|---|---|---|---|
||||||2020f|2019f|
|Net income fcr the|period (as per|Statement||of Financial Activities)|45,390|230,457|
|Adjustments
for:|||||||
|Depreciation
charges|||||3,478|3,063|
|(Gains)/ losses on|investments||||104,301|(151,186)|
|Dividends,
interests|and rents from||investments||(299)|(642)|
|Decrease
in stocks||||||4,022|
|Decrease/(increase)|in debtors||||(42,895)|31,194|
|Decrease
in creditors|||||(66,905)|(1,507)|
|Net cash provided|by operating|activities|||43,070|115,401|
##
##
|||2020f|2019f|
|---|---|---|---|
|Cash|in hand|570,835|529,271|
|Total|cash and cash equivalents|570,835|529,271|
##
||||At 1||At 31|
|---|---|---|---|---|---|
||||January||December|
||||2020|Cash flows|2020|
||||6||F|
|Cash at bank and||in hand|529,271|41,564|570,835|
|Debt due within|1|year|(3,317)|2,227|(1,090)|
|Finance leases|||(2,356)|673|(1,683)|
||||523,598|44,464|568,062|
##
##
|Reconcilia|tion
ofmove|ments
in unr|ealised
gains on the investm|ent
asset||
|---|---|---|---|---|---|
|||||2020|2019|
|||||5||
|Unrealised|gains at 1 January|||658,881|507,695|
|Unrealised|gain/(losses)|on revaluation|at 31 December|(104,301)|151,186|
|Unrealised|gains at 31|December||554,580|658,881|
##
##
##
##
||||2020f|2019f|
|---|---|---|---|---|
|Not later than||1 year|32,250|32,250|
|Later than|1 year and not later than 5 years||64,500|96,750|
||||96,750|129,000|
##
|||2020f|2019
F|
|---|---|---|---|
|Donations|received|425|525|
|||425|525|
##